GO:0045202 synapse: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045202 (synapse) is the cellular component describing the junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber, or a glial cell.
• Synapse formation requires presynaptic terminal boutons containing mitochondria and synaptic vesicles, a synaptic cleft, and a postsynaptic membrane specialized for neurotransmitter reception.
• Synapse organizers are molecular codes that instruct synaptic plasticity and specify excitatory versus inhibitory synapse identity.
• Astrocytes and microglia actively eliminate synapses via complement C1q-dependent phagocytosis, a mechanism implicated in Alzheimer's disease.
• Synapse vulnerability and resilience are central to the clinical spectrum of dementias, making synaptic components high-value therapeutic targets.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of synapse-related genes in relevant cellular and animal systems.
Description
The synapse (GO:0045202) is the fundamental cellular component through which neurons communicate, forming the junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber, or a glial cell. As the axon approaches the synapse, it enlarges into a specialized presynaptic terminal bouton containing mitochondria and synaptic vesicles; at its tip lies the presynaptic membrane, facing a specialized postsynaptic membrane across the synaptic cleft. In response to nerve impulses, the presynaptic terminal secretes neurotransmitters into the cleft, where they diffuse and transmit the signal to the postsynaptic membrane. This architecture is not static: synapse organizers act as molecular codes that instruct synaptic plasticity and specify the properties of excitatory and inhibitory connections. Researchers study GO:0045202 because synaptic dysfunction is an early and central feature of Alzheimer's disease and related dementias, and because synapse vulnerability versus resilience shapes clinical trajectories across the dementia spectrum. Astrocytes and microglia contribute to synapse elimination through complement C1q-dependent phagocytosis, and astrocyte-secreted factors such as neurocan control inhibitory synapse formation and function, underscoring that the synapse is a multi-cellular compartment. Understanding the molecular composition, assembly, and regulation of the synapse is therefore essential for mechanistic neuroscience and for developing synapse-directed therapeutics.
synapse At A Glance
| GO ID | GO:0045202 |
|---|---|
| GO term | synapse |
| Ontology | cellular_component |
| Synonym | electrotonic synapse; mixed synapse; synaptic junction |
| Major function | Junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber, or a glial cell, enabling neurotransmitter release and signal transmission |
| Presynaptic specialization | Terminal bouton containing mitochondria and synaptic vesicles, with a presynaptic membrane at its tip |
| Postsynaptic specialization | Specialized area of membrane on the receiving cell, separated from the presynaptic membrane by the synaptic cleft |
| Signal transmission mode | Nerve impulse-evoked secretion of neurotransmitters into the synaptic cleft, followed by diffusion and reception at the postsynaptic membrane |
| Cellular participants | Neurons, muscle fibers, glial cells, and astrocytes/microglia that remodel synapses |
What Is GO:0045202?
In the Gene Ontology, GO:0045202 (synapse) is a cellular component defined as the junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber, or a glial cell. The axon enlarges at the synapse into a specialized presynaptic terminal bouton that contains mitochondria and synaptic vesicles; at the tip of the bouton is the presynaptic membrane, which faces a specialized postsynaptic membrane across a minute synaptic cleft. Upon arrival of nerve impulses, the presynaptic terminal bouton secretes neurotransmitter molecules into the synaptic cleft, and these diffuse across the cleft to transmit the signal to the postsynaptic membrane. Synonyms include electrotonic synapse, mixed synapse, and synaptic junction.
Why Is synapse Important in Cell Biology?
The synapse is the principal site of information transfer in the nervous system, and its molecular organization determines how circuits form, mature, and adapt. Because synapse organizers encode plasticity rules and specify excitatory versus inhibitory synapse properties, they are central to understanding learning, memory, and circuit homeostasis. Synapse pathology is an early and robust correlate of cognitive decline in Alzheimer's disease, and synapse vulnerability versus resilience tracks across the clinical spectrum of dementias. Non-neuronal cells, including astrocytes and microglia, actively eliminate synapses via complement C1q-dependent phagocytosis and control inhibitory synapse formation through secreted factors such as neurocan, making the synapse a multi-cellular and dynamically regulated compartment. Consequently, synapse-focused research informs biomarker discovery, therapeutic target selection, and mechanistic models of neurodevelopmental and neurodegenerative disease.
• Defines the structural and functional unit of neuronal communication, including presynaptic boutons, synaptic cleft, and postsynaptic membrane.
• Provides the molecular framework for synaptic plasticity through synapse organizers that act as molecular codes.
• Is a primary locus of pathology in Alzheimer's disease, where synapse loss correlates with cognitive impairment.
• Underlies synapse vulnerability and resilience that shape the clinical spectrum of dementias.
• Involves astrocyte-secreted factors such as neurocan that control inhibitory synapse formation and function.
• Is remodeled by astrocytes and microglia through complement C1q-dependent synapse elimination.
• Serves as a target for CRISPR-based causal testing of candidate genes in synaptic biology.
• Connects to circuit-level phenotypes relevant to neurodevelopmental and neurodegenerative disorders.
• Enables mechanistic dissection of excitatory versus inhibitory synapse specification.
• Supports development of synapse-directed biomarkers and therapeutic strategies.
What Happens During synapse?
Presynaptic terminal differentiation and vesicle organization
In simple terms: The sending side of the neuron builds a specialized ending that stores and releases chemical signals.
As the axon approaches the synapse, it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane, which is positioned to release neurotransmitter into the synaptic cleft upon nerve impulse arrival. The cell biology of synapse formation involves coordinated assembly of presynaptic release machinery and vesicle pools, a process reviewed in detail by Südhof.
Synaptic cleft and neurotransmitter release
In simple terms: A tiny gap separates the two cells, and chemical messengers diffuse across it.
Facing the presynaptic membrane, and separated from it by a minute cleft (the synaptic cleft), is a specialized area of membrane on the receiving cell known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft; these diffuse across the cleft and transmit the signal to the postsynaptic membrane. This release-and-diffusion mechanism is the core of chemical synaptic transmission as defined for GO:0045202.
Postsynaptic reception and synapse organizer codes
In simple terms: The receiving side interprets the signal, guided by organizer proteins that define synapse type.
The postsynaptic membrane is a specialized area of membrane on the receiving cell that receives neurotransmitter signals diffusing across the synaptic cleft. Synapse organizers act as molecular codes for synaptic plasticity, instructing the functional properties of excitatory and inhibitory connections. These organizer systems help specify synapse identity and plasticity rules, linking structural assembly to functional adaptation.
Astrocyte- and microglia-dependent synapse remodeling
In simple terms: Support cells in the brain can remove or shape synapses, refining circuits.
Astrocyte-secreted neurocan controls inhibitory synapse formation and function, demonstrating that glial cells actively instruct synapse assembly. Astrocyte-dependent circuit remodeling occurs by synapse phagocytosis, in which astrocytes eliminate synapses to refine circuits. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia has been demonstrated in Alzheimer's disease mouse models, linking immune-complement mechanisms to synapse removal.
Synapse vulnerability and resilience in disease
In simple terms: Some synapses are lost early in disease, while others resist degeneration.
Synapse pathology is a prominent feature of Alzheimer's disease, and synapse vulnerability and resilience underlie disease progression. Synapse vulnerability and resilience have been characterized across the clinical spectrum of dementias, indicating that synaptic phenotypes track with disease stage. These observations position synapse maintenance and elimination pathways as key processes for mechanistic and therapeutic investigation.
Key Genes Involved in GO:0045202 synapse
The following genes and proteins represent core synaptic components, organizers, and glial regulators that are widely studied in the context of GO:0045202 (synapse).
| Gene | Major Role | Research Relevance |
|---|---|---|
| C1QA | Complement component C1q subunit involved in synapse elimination | Required for C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease models |
| C1QB | Complement component C1q subunit involved in synapse elimination | Part of the C1q complex that tags synapses for phagocytic removal |
| C1QC | Complement component C1q subunit involved in synapse elimination | Contributes to complement-mediated synapse pruning |
| NCAN | Astrocyte-secreted neurocan controlling inhibitory synapse formation | Regulates inhibitory synapse formation and function |
| GPC4 | Astrocyte-secreted factor implicated in synapse formation | Studied as a glial signal for synapse assembly |
| GPC6 | Astrocyte-secreted factor implicated in synapse formation | Studied as a glial signal for synapse assembly |
| THBS1 | Astrocyte-secreted thrombospondin implicated in synapse formation | Studied as a glial signal for synapse assembly |
| THBS2 | Astrocyte-secreted thrombospondin implicated in synapse formation | Studied as a glial signal for synapse assembly |
| NRXN1 | Presynaptic adhesion molecule and synapse organizer | Functions as a molecular code for synaptic plasticity |
| NRXN2 | Presynaptic adhesion molecule and synapse organizer | Functions as a molecular code for synaptic plasticity |
| NRXN3 | Presynaptic adhesion molecule and synapse organizer | Functions as a molecular code for synaptic plasticity |
| NLGN1 | Postsynaptic adhesion molecule and synapse organizer | Functions as a molecular code for synaptic plasticity |
| NLGN2 | Postsynaptic adhesion molecule and synapse organizer | Functions as a molecular code for synaptic plasticity |
| NLGN3 | Postsynaptic adhesion molecule and synapse organizer | Functions as a molecular code for synaptic plasticity |
| NLGN4X | Postsynaptic adhesion molecule and synapse organizer | Functions as a molecular code for synaptic plasticity |
| LRRTM1 | Postsynaptic organizer of excitatory synapses | Functions as a molecular code for synaptic plasticity |
| LRRTM2 | Postsynaptic organizer of excitatory synapses | Functions as a molecular code for synaptic plasticity |
| SYP | Synaptic vesicle protein used as a synapse marker | Used to assess synapse density and pathology in Alzheimer's disease |
How Is synapse Regulated?
Synapse formation and elimination are regulated by coordinated interactions between neuronal adhesion/organizer systems and glial signals. Synapse organizers act as molecular codes that specify plasticity rules and synapse identity, thereby regulating how synapses strengthen or weaken. Astrocyte-secreted neurocan controls inhibitory synapse formation and function, providing a glial regulatory input to inhibitory synapse assembly. Astrocyte-dependent circuit remodeling by synapse phagocytosis further regulates synapse number and circuit refinement. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia provides an immune-complement regulatory mechanism for synapse removal, and this pathway is altered in Alzheimer's disease mouse models. Together, these mechanisms regulate synapse vulnerability and resilience across disease states.
synapse and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| C1QA | Complement-dependent synapse elimination in Alzheimer's disease | Knockout in mouse models to test synapse loss |
| NCAN | Inhibitory synapse formation and function | Knockout or overexpression in astrocyte-neuron co-cultures |
| NRXN1 | Synaptic plasticity and synapse organizer function | Knockout in human iPSC-derived neurons |
| NLGN1 | Synaptic plasticity and synapse organizer function | Knockout or point mutation in rodent neurons |
| SYP | Synapse density marker in Alzheimer's disease | Knock-in tagging for imaging synapse density |
Alzheimer's disease and synapse pathology
Synapse pathology is a central feature of Alzheimer's disease, and synapse loss is closely associated with cognitive decline. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia has been demonstrated in Alzheimer's disease mouse models, implicating immune-complement pathways in synapse removal. Synapse vulnerability and resilience underlie Alzheimer's disease progression, suggesting that preserving resilient synapses may be therapeutically relevant.
Synapse vulnerability and resilience across dementias
Synapse vulnerability and resilience have been characterized across the clinical spectrum of dementias, indicating that synaptic phenotypes vary with disease stage and subtype. This spectrum-level view supports the use of synaptic markers and mechanisms as translational readouts in dementia research.
Glial regulation of synapses in disease
Astrocytes and microglia actively remodel synapses through phagocytosis, and astrocyte-secreted neurocan controls inhibitory synapse formation and function. These glial mechanisms can become dysregulated in disease, contributing to synapse loss and circuit dysfunction.
From synapse-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for synapse formation? | CRISPR knockout in iPSC-derived neurons or rodent primary neurons |
| Does a disease-associated variant alter synaptic function? | CRISPR point mutation knock-in in isogenic cell lines |
| Where does a synaptic protein localize? | CRISPR knock-in of fluorescent or epitope tags |
| Does overexpression of a glial factor change synapse number? | CRISPR overexpression in astrocytes or co-culture systems |
| Does complement activation drive synapse elimination? | Knockout of C1q subunits in Alzheimer's disease mouse models |
| Which genes regulate synapse vulnerability? | CRISPR library screening in neuronal cultures followed by imaging |
How to Study the synapse Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal imaging of synaptic markers | Synapse density and colocalization | Assessing synapse loss in disease models |
| Electrophysiology | Synaptic transmission strength | Testing functional consequences of gene perturbation |
| RNA sequencing | Transcriptomic changes in synaptic genes | Identifying synapse vulnerability signatures |
| Proteomics | Synaptic protein composition | Characterizing synapse organizers and receptors |
| Phagocytosis assays | Astrocyte/microglia-mediated synapse elimination | Modeling complement-dependent synapse pruning |
| Co-culture systems | Glial regulation of synapse formation | Testing astrocyte-secreted factors such as neurocan |
| CRISPR screening | Gene requirements for synapse phenotypes | Discovering regulators of synapse formation and maintenance |
Imaging-based synapse quantification
Synapse density and structure can be assessed by imaging presynaptic and postsynaptic markers, including synaptic vesicle proteins such as SYP, in cell culture and tissue sections. Co-culture systems with astrocytes and neurons allow visualization of glial effects on inhibitory synapse formation.
Transcriptomic and proteomic profiling
RNA sequencing and proteomics can identify synapse-enriched gene expression programs and protein composition changes in disease models. These approaches help link candidate genes to synapse vulnerability and resilience signatures.
Functional assays of synaptic transmission
Electrophysiological and functional assays measure neurotransmitter release and postsynaptic responses, providing direct readouts of synapse function. Such assays are used to test the consequences of synapse organizer perturbations.
Phagocytosis and synapse elimination assays
Astrocyte- and microglia-dependent synapse phagocytosis can be assayed using complement C1q-dependent elimination paradigms in mouse models. These assays quantify excitatory and inhibitory synapse removal and circuit remodeling.
How CRISPR Can Be Used to Study GO:0045202 synapse
Knockout
CRISPR knockout of synapse-related genes, such as NRXN1 or NLGN1, enables loss-of-function testing of their requirement for synapse formation and plasticity. Knockout of complement C1q subunits in mouse models can test their role in synapse elimination.
Point Mutation
CRISPR point mutation knock-in allows introduction of disease-associated variants into endogenous synapse genes to test effects on synaptic function and organizer activity. This approach preserves endogenous regulatory context while altering a single residue.
Knock-in
CRISPR knock-in of fluorescent or epitope tags into synaptic genes enables visualization of endogenous proteins at synapses. Tagged knock-in models are valuable for tracking synapse organizer localization and dynamics.
Overexpression
CRISPR-mediated overexpression of astrocyte-secreted factors such as neurocan can test sufficiency for altering inhibitory synapse formation and function. Overexpression models complement knockout approaches by probing gain-of-function effects on synapse number and plasticity.
How EDITGENE Supports synapse Research
Researchers studying synapse-related genes often need to determine whether a candidate gene is causally involved in synapse formation, maintenance, or elimination, rather than merely correlated with synaptic phenotypes. CRISPR-based models provide the controlled genetic perturbations required to establish causality in neuronal and glial systems. EDITGENE supports this workflow with end-to-end cell model generation and screening services tailored to synaptic biology.
Contact EDITGENE today to design your custom CRISPR model for synapse research.
Frequently Asked Questions About synapse
What is GO:0045202 synapse?
GO:0045202 is the Gene Ontology cellular component term for the junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber, or a glial cell, including the presynaptic terminal bouton, synaptic cleft, and postsynaptic membrane.
What genes are involved in synapse formation?
Genes encoding synapse organizers such as NRXN1, NLGN1, and LRRTM family members, as well as astrocyte-secreted factors like NCAN, are involved in synapse formation and function.
How is the synapse defined in the Gene Ontology?
The synapse is defined as the junction where the presynaptic terminal bouton secretes neurotransmitters into the synaptic cleft, which diffuse to the postsynaptic membrane to transmit signals.
What is the role of astrocytes in synapse regulation?
Astrocytes secrete factors such as neurocan that control inhibitory synapse formation and function, and they can eliminate synapses through phagocytosis.
How does complement C1q contribute to synapse elimination?
Complement C1q-dependent mechanisms mediate excitatory and inhibitory synapse elimination by astrocytes and microglia, as shown in Alzheimer's disease mouse models.
Why is synapse pathology important in Alzheimer's disease?
Synapse pathology is a key feature of Alzheimer's disease and is linked to cognitive decline, with synapse vulnerability and resilience underlying disease progression.
What research methods are used to study synapses?
Common methods include imaging of synaptic markers, electrophysiology, RNA sequencing, proteomics, phagocytosis assays, and CRISPR screening.
How can CRISPR be used to study synapse genes?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of synapse-related genes in neuronal and glial systems.
What is synapse vulnerability and resilience?
Synapse vulnerability and resilience describe the differential susceptibility of synapses to degeneration versus preservation, and these properties track across the clinical spectrum of dementias.
What are synapse organizers?
Synapse organizers are molecular codes that instruct synaptic plasticity and specify the properties of excitatory and inhibitory synapses.
Conclusion
GO:0045202 (synapse) defines the essential cellular junction for neuronal communication, encompassing the presynaptic terminal bouton, synaptic cleft, and postsynaptic membrane. Its molecular organization is governed by synapse organizers that encode plasticity rules, and it is dynamically regulated by astrocytes and microglia through secreted factors and complement-dependent elimination. Synapse pathology and synapse vulnerability versus resilience are central to Alzheimer's disease and the broader spectrum of dementias, making synaptic components high-priority research and therapeutic targets. CRISPR-based knockout, point-mutation, knock-in, overexpression, and screening approaches provide the causal genetic tools needed to dissect synapse biology and translate findings toward clinical impact.
References
- 1. Südhof TC. 2021. The cell biology of synapse formation.. J Cell Biol 220(7) PMID: 34086051
- 2. Griffiths J et al.. 2023. Synapse pathology in Alzheimer's disease.. Semin Cell Dev Biol 139:13-23 PMID: 35690535
- 3. Connor SA et al.. 2023. Synapse organizers as molecular codes for synaptic plasticity.. Trends Neurosci 46(11):971-985 PMID: 37652840
- 4. Irala D et al.. 2024. Astrocyte-secreted neurocan controls inhibitory synapse formation and function.. Neuron 112(10):1657-1675.e10 PMID: 38574730
- 5. Dejanovic B et al.. 2022. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models.. Nat Aging 2(9):837-850 PMID: 37118504
- 6. Taddei RN et al.. 2025. Synapse vulnerability and resilience underlying Alzheimer's disease.. EBioMedicine 112:105557 PMID: 39891995
- 7. Taddei RN et al.. 2025. Synapse vulnerability and resilience across the clinical spectrum of dementias.. Nat Rev Neurol 21(7):353-369 PMID: 40404832
- 8. Park J et al.. 2023. Astrocyte-dependent circuit remodeling by synapse phagocytosis.. Curr Opin Neurobiol 81:102732 PMID: 37247606
